Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand Alone Graft

Clinical application of umbilical cord blood (UCB) as a source of hematopoietic stem cells for transplantation is limited by low CD34+ cell dose, increased risk of graft failure and slow hematopoietic recovery. While the cell dose limitation is partially mitigated by using two UCB units, larger dose...

詳細記述

保存先:
書誌詳細
出版年:Cell Stem Cell
主要な著者: Wagner, John E., Brunstein, Claudio G., Boitano, Anthony E., DeFor, Todd E., McKenna, David, Sumstad, Darin, Blazar, Bruce R., Tolar, Jakub, Le, Chap, Jones, Julie, Cooke, Michael P., Bleul, Conrad C.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881386/
https://ncbi.nlm.nih.gov/pubmed/26669897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2015.10.004
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料